How Biosimilar Drug Approvals Provide Opportunities for Pharmacists

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.

Related Videos
Credit: wladimir1804 - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Women buying contraceptive pills in the pharmacy | Image credit: Antonioguillem - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Medical science laboratory | Image credit: alphaspirit - stock.adobe.com
Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com
Supreme Court | Image credit: steheap - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.